|
Vol. 11.07 – 23 February, 2022
|
|
|
|
|
|
Researchers identified USP33 as essential deubiquitinase that stabilized HIF-2alpha protein in an ERK1/2-dependent manner to promote hypoxia response in cancer cells.
[EMBO Journal]
|
|
|
|
|
PUBLICATIONSRanked by the impact factor of the journal
|
|
|
|
|
The in vitro and in vivo results indicated that CD133+ stem cell-like cells were the main subpopulation and PARP1 was the central gene mediating oxaliplatin resistance in gastric cancer. [Cellular and Molecular Life Sciences]
|
|
|
|
|
Scientists showed that microglial morphology and functions were already impaired during glioma initiation stages.
[Glia]
|
|
|
|
|
Biological and molecular alterations upon family with sequence similarity 83 member A (FAM83A) overexpression/downregulation and FAM83A’s interaction partners were investigated.
[Biomarker Research]
|
|
|
|
|
All isolated analogues were screened for the cytotoxicity against intrahepatic cholangiocarcinoma cell lines of HuCCT1 and RBE through tumor colony formation and CCK-8 survival analysis.
[Bioorganic Chemistry]
|
|
|
|
|
Gene knockout studies revealed that SOX2 was an essential factor for the generation of CSCs by HRASV12 in mouse and human fibroblasts.
[Scientific Reports]
|
|
|
|
|
Scientists established a novel method to generate CSCs from iPSCs under a cancerous microenvironment mimicked by the conditioned medium of cancer-derived cells.
[Scientific Reports]
|
|
|
|
|
Researchers sequenced the piRNAs, miRNAs and mRNAs of Piwil2-iCSCs and fibroblasts, and analyzed the differences.
[Molecular Biology Reports]
|
|
|
|
|
Scientists investigated the impact of shortened telomeres in a mouse model for Barrett esophagus (L2-IL1B). The L2-IL1B mouse model was characterized by IL-1β-mediated inflammation, which led to a Barrett-like metaplasia in the transition zone between the squamous forestomach and glandular cardia/stomach.
[Oncotarget]
|
|
|
|
|
|
|
The authors review the progress made in the development of CRISPR systems as a tool to study cancer, and the emerging adaptation of these technologies to improve diagnosis and treatment. [Nature Reviews Cancer]
|
|
|
|
|
Scientists summarize the major recent works on the use of antibiotics to target tumors via CSC and suggest next steps for developing this approach. [Biochemical Pharmacology]
|
|
|
|
|
|
Ayala Pharmaceuticals, Inc. announced that it has completed patient enrollment in Part A of the Phase II/III RINGSIDE clinical trial evaluating AL102 in desmoid tumors.
[Ayala Pharmaceuticals, Inc.]
|
|
|
|
|
|
|
|
|
Baylor College of Medicine – Houston, Texas, United States
|
|
|
|
|
BC Cancer Research Institute – BC Cancer Research Institute
|
|
|
|
|
Florida International University – Miami, Florida, United States
|
|
|
|
|
Albert Einstein College of Medicine – Bronx, New York, United States
|
|
|
|
|
Moffit Cancer Center – Tampa Bay, Florida, United States
|
|
|
|
|